HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-144 Cr | ₹-27 Cr | ₹-7.68 Cr | ₹-5.56 Cr | ₹-97 Cr |
What is the latest Cash Flow from Financing Activities ratio of HIKAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-144 Cr |
| Mar2024 | ₹-27 Cr |
| Mar2023 | ₹-7.68 Cr |
| Mar2022 | ₹-5.56 Cr |
| Mar2021 | ₹-97 Cr |
How is Cash Flow from Financing Activities of HIKAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-144 Cr | Negative | |
| Mar2024 | ₹-27 Cr | Negative | |
| Mar2023 | ₹-7.68 Cr | Negative | |
| Mar2022 | ₹-5.56 Cr | Negative | |
| Mar2021 | ₹-97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,238.5 Cr | -3.8% | 7.6% | -55.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -3.8% |
7.6% |
-55.9% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses